How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Therapy Market
- By Therapy Type: Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Psychodynamic Therapy, Humanistic Therapy, Family Therapy, Group Therapy
- By Delivery Mode: In-person Therapy, Online Therapy (Teletherapy), Hybrid Therapy, Mobile App-based Therapy, Telephone Therapy
- By Target Condition: Depression, Anxiety Disorders, Post-Traumatic Stress Disorder (PTSD), Substance Use Disorders, Eating Disorders, Bipolar Disorder
- By Provider Type: Licensed Psychologists, Psychiatrists, Licensed Clinical Social Workers (LCSW), Licensed Professional Counselors (LPC), Marriage and Family Therapists (MFT)
- By Patient Age Group: Children and Adolescents, Adults, Older Adults
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cognitive Behavioral Therapy (CBT) leads By Therapy Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 306 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.185 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.193 →
Full report · locked preview
Everything inside the Therapy Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →UnitedHealth Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Anthem Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →CVS Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cigna Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Humana Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Teladoc Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Optum
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Magellan Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Centene Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Molina Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Beacon Health Options
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Acadia Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Universal Health Services
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →HCA Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Community Health Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cognitive Behavioral Therapy (CBT)46.4
- Dialectical Behavior Therapy (DBT)12.6
- Psychodynamic Therapy11.1
- Humanistic Therapy14.8
- Family Therapy7.0
- Group Therapy8.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- UnitedHealth Group16.0
- Anthem Inc.17.1
- CVS Health13.5
- Cigna Corporation7.4
- Humana Inc.13.2
- Teladoc Health4.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.4
- Europe22.7
- Asia Pacific21.4
- Latin America13.0
- Middle East and Africa11.3
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group | 79 | 87 | 76 | 93 | 95 | 74 | 84 |
| Anthem Inc. | 78 | 90 | 75 | 88 | 83 | 81 | 83 |
| CVS Health | 69 | 71 | 77 | 65 | 76 | 88 | 74 |
| Cigna Corporation | 77 | 78 | 63 | 70 | 81 | 67 | 73 |
| Humana Inc. | 55 | 72 | 53 | 76 | 57 | 59 | 62 |
| Teladoc Health | 59 | 46 | 56 | 52 | 57 | 65 | 56 |
| Optum | 43 | 51 | 47 | 44 | 58 | 46 | 48 |
| Magellan Health | 60 | 59 | 38 | 52 | 47 | 46 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- UnitedHealth Group
- Anthem Inc.
- CVS Health
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| UnitedHealth Group | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Anthem Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| CVS Health | ◐ | ◐ | ✓ | − | ◐ | ◐ |
| Cigna Corporation | ◐ | ✓ | − | ✓ | ◐ | ✓ |
| Humana Inc. | − | ◐ | − | ✓ | ◐ | ◐ |
| Teladoc Health | ◐ | − | − | ◐ | − | − |
| Optum | − | ◐ | − | − | − | − |
| Magellan Health | ◐ | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Therapy Type in North America, then scale across Therapy Market — a $164M beachhead inside a $2.54B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Cognitive Behavioral Therapy (CBT)
Best fit — highest urgency & budget in Therapy Type.
Dialectical Behavior Therapy (DBT)
Strong fit — clear ROI and a fast path to value.
Psychodynamic Therapy
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Therapy Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Delivery Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Condition
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Therapy Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Therapy Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Therapy Market is a durable-growth opportunity — $7.87B by 2033, compounding at 9.3%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Therapy Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Therapy Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Delivery Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Therapy Market — a $2.89B market by 2033. Plan: grow share from 12.1% to 18.9%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 12.1% | 18.9% | At risk |
| Revenue | $325M | $547M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.4% | 38.3% | On track |
| Customer retention | 91.2% | 92.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Therapy Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Delivery Mode capability
A defensible second engine — invest in Delivery Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Therapy Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Delivery Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $66M capacity & capability investment
- Greenlight bolt-on M&A in Delivery Mode
- Authorise North America expansion plan
- Fund R&D program for Therapy Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentBehind
Sales deck · value proposition
Win the Therapy Market conversation — a $3.77B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Therapy Type
Goal Grow share in Therapy Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Therapy Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Therapy Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Therapy Wound Care Devices Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTherm Pasteurizer Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThermage Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThermal Adhesive Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThermal Air Filtration Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThermal Analysis Spectrometer Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportThermal and Airbag Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThermal Barrier Antisepsis Coating Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportThermal Black Market
Market size, share, segmentation and regional forecast.
$453M market · 2025 base year
View reportThermal Ceramic Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportThermal Conductive Adhesive for Battery Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThermal Conductive and Insulating Paste Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy